OTCMKTS:SWTUY - SWEDISH ORPHAN/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$25.29 +2.62 (+11.56 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$25.29
Today's Range$25.03 - $25.29
52-Week Range$14.23 - $31.96
Volume592 shs
Average Volume65 shs
Market Capitalization$6.89 billion
P/E Ratio50.58
Dividend YieldN/A
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.

Receive SWTUY News and Ratings via Email

Sign-up to receive the latest news and ratings for SWTUY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:SWTUY



Sales & Book Value

Annual Sales$763.19 million
Cash Flow$0.7035 per share
Book Value$2.88 per share


Net Income$134.73 million


Market Cap$6.89 billion
OptionableNot Optionable

SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Frequently Asked Questions

What is SWEDISH ORPHAN/S's stock symbol?

SWEDISH ORPHAN/S trades on the OTCMKTS under the ticker symbol "SWTUY."

How were SWEDISH ORPHAN/S's earnings last quarter?

SWEDISH ORPHAN/S (OTCMKTS:SWTUY) announced its quarterly earnings results on Wednesday, October, 31st. The company reported $0.26 earnings per share for the quarter, missing analysts' consensus estimates of $0.28 by $0.02. The company earned $258.63 million during the quarter, compared to analysts' expectations of $261.25 million. SWEDISH ORPHAN/S had a net margin of 25.75% and a return on equity of 29.63%. View SWEDISH ORPHAN/S's Earnings History.

When is SWEDISH ORPHAN/S's next earnings date?

SWEDISH ORPHAN/S is scheduled to release their next quarterly earnings announcement on Thursday, February 28th 2019. View Earnings Estimates for SWEDISH ORPHAN/S.

What is the consensus analysts' recommendation for SWEDISH ORPHAN/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SWEDISH ORPHAN/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SWEDISH ORPHAN/S.

Has SWEDISH ORPHAN/S been receiving favorable news coverage?

News coverage about SWTUY stock has been trending neutral on Sunday, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SWEDISH ORPHAN/S earned a news sentiment score of 0.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are some of SWEDISH ORPHAN/S's key competitors?

Who are SWEDISH ORPHAN/S's key executives?

SWEDISH ORPHAN/S's management team includes the folowing people:
  • Dr. Guido Oelkers, CEO & Pres (Age 53)
  • Mr. Henrik Stenqvist, Chief Financial Officer (Age 51)
  • Ms. Anne Marie de Jonge Schuermans, Head of Technical Operations
  • Mr. Jorgen L. Winroth, VP & Head of Investor Relations
  • Mr. Torbjörn Hallberg, Gen. Counsel & Head of Legal Affairs (Age 49)

How do I buy shares of SWEDISH ORPHAN/S?

Shares of SWTUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SWEDISH ORPHAN/S's stock price today?

One share of SWTUY stock can currently be purchased for approximately $25.29.

How big of a company is SWEDISH ORPHAN/S?

SWEDISH ORPHAN/S has a market capitalization of $6.89 billion and generates $763.19 million in revenue each year. The company earns $134.73 million in net income (profit) each year or $0.50 on an earnings per share basis. SWEDISH ORPHAN/S employs 800 workers across the globe.

What is SWEDISH ORPHAN/S's official website?

The official website for SWEDISH ORPHAN/S is http://www.sobi.com.

How can I contact SWEDISH ORPHAN/S?

SWEDISH ORPHAN/S's mailing address is Tomtebodavagen 23A, Stockholm V7, 112 76. The company can be reached via phone at 46-0-869-720-00 or via email at [email protected]

MarketBeat Community Rating for SWEDISH ORPHAN/S (OTCMKTS SWTUY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  87 (Vote Outperform)
Underperform Votes:  113 (Vote Underperform)
Total Votes:  200
MarketBeat's community ratings are surveys of what our community members think about SWEDISH ORPHAN/S and other stocks. Vote "Outperform" if you believe SWTUY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SWTUY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Featured Article: What is the S&P 500 Index?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel